Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 118, pseudogene (RN7SL118P)

Target
RN7SL118P
Molecular classification
Non-coding RNA, Pseudogene
01

Overview

RNA, 7SL, cytoplasmic 118, pseudogene (RN7SL118P) is a human gene classified as a pseudogene, specifically one of the many pseudogenes derived from the 7SL RNA gene. 7SL RNA itself is a functional component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the targeting of proteins to the endoplasmic reticulum[1][3][7]. However, RN7SL118P represents a non-functional, non-coding copy (pseudogene) that arose through reverse transcription and reintegration of 7SL RNA sequences into genomic DNA[7]. As with other 7SL RNA pseudogenes, RN7SL118P is generally not transcribed into a functional RNA product, and there is no evidence suggesting it serves a biological function or that it acts as a therapeutic target[5][6][7]. Pseudogenes like RN7SL118P are not associated with disease roles, drug interactions, or biomarker utility, and are not considered druggable or therapeutic targets. Key context and supporting details: - RN7SL118P appears in gene databases as a pseudogene and is not listed with any synonyms or associated functional annotations[5][6]. - The majority of 7SL-derived loci in the human genome are pseudogenes, not the functional 7SL RNA genes; they do not encode functional RNA or protein products and are not involved in cellular signaling, enzymatic activity, transport, transcription, or other actionable biological roles[7]. - Pseudogenes may occasionally influence gene expression by "decoy" effects (e.g., as sources of small interfering RNA), but there is no data supporting this for RN7SL118P specifically[2].

Other names
RN7SL118P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 118, pseudogene (RN7SL118P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 118, pseudogene (RN7SL118P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call